Physician profile
Veronica D Kim
NPI 1710949458
$1,978.13
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $241 · 2021: $134 · 2022: $44.48 · 2024: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $292.67 | 2019-2024 | |
| Lilly USA, LLC | $182.15 | 2019-2024 | Zepbound |
| Novartis Pharmaceuticals Corporation | $171.18 | 2019-2020 | |
| Pfizer INC. | $159.78 | 2019-2020 | |
| Amarin Pharma, INC. | $158.25 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $151.42 | 2019-2020 | |
| Amgen INC. | $134.99 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $115.00 | 2021 | |
| Celgene Corporation | $105.40 | 2019 | |
| Ucb, INC. | $80.01 | 2019-2020 | |
| Astellas Pharma US INC | $66.66 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $62.17 | 2019 | |
| Novo Nordisk INC | $57.07 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.39 | 2019 | |
| Sanofi Pasteur INC. | $31.65 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $27.79 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.76 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.02 | 2019 | |
| Daiichi Sankyo INC. | $19.71 | 2019 | |
| Bioventus LLC | $18.76 | 2019 | |
| Allergan, INC. | $17.11 | 2019 | |
| Shire North American Group INC | $14.28 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.64 | 2019 | |
| Horizon Therapeutics Plc | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.